Intelligent Autoimmune Disease Prevention and Treatment System

A synergistic system integrating AI, IoT, blockchain, and nanomaterials to diagnose, predict, and treat autoimmune diseases by targeting pathogenic age-associated B cells, providing personalized medicine and improving treatment outcomes.

The original patent addressed the limitations of current autoimmune disease treatments by targeting pathogenic age-associated B cells. However, it lacked a comprehensive approach to diagnose, predict, and treat autoimmune diseases. This new inventive concept addresses these limitations by integrating distinct technologies to provide a more effective and personalized solution.

The system consists of a machine learning module trained on a dataset of pathogenic age-associated B cell characteristics, a blockchain-based data storage module for secure storage of patient data, and IoT-enabled wearable devices for monitoring patient health metrics. The AI-powered personalized medicine analyzes the health metrics and provides treatment recommendations. The system also includes a nanomaterial-based delivery system for targeted delivery of nucleic acids encoding human DEF6 protein and human SWAP-70 protein to pathogenic age-associated B cells. Additionally, the system features an AI-powered diagnostic module for real-time monitoring of treatment efficacy and a blockchain-based simulation platform for validating novel therapeutic targets.

The new claims introduce a synergistic combination of AI, IoT, blockchain, and nanomaterials, which is novel and non-obvious compared to the original patent. The integration of these distinct technologies provides a more comprehensive and effective solution for autoimmune disease diagnosis, prediction, and treatment.

Alternative embodiments include using different machine learning algorithms, varying the type of IoT-enabled devices, or incorporating additional technologies such as robotics or 3D printing. Variations of the system could be tailored to specific autoimmune diseases or patient populations, further expanding its applicability.

The Intelligent Autoimmune Disease Prevention and Treatment System has significant commercial potential in the healthcare industry, particularly in the fields of personalized medicine, precision health, and digital therapeutics. The system could be marketed to pharmaceutical companies, healthcare providers, and medical research institutions, offering a competitive advantage in autoimmune disease diagnosis and treatment.